SCHEMBL15033394

SCHEMBL15033394

Bc1occc1C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19138056 0.74 ALDH1A1 (0.44)
SCHEMBL51408 0.72
SCHEMBL28562323 0.70 ALDH1A1 (0.41)
SCHEMBL22612036 0.70
SCHEMBL28830723 0.70
Water SCHEMBL15210122 0.70 ALDH1A1 (0.41)
Water SCHEMBL3454746 0.70 ALDH1A1 (0.41)
SCHEMBL1703143 0.70
SCHEMBL686972 0.70
SCHEMBL644095 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3045449-A1 TETRACYCLINE DERIVATIVES FOR THE TREATMENT OF BACTERIAL, VIRAL AND PARASITIC INFECTIONS Paratek Pharmaceuticals, Inc. (US) 2016-07-20 EP disclosed
EP-2450347-B1 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections PARATEK PHARM INNC (US) 2015-06-24 EP disclosed
EP-2109602-B1 TETRACYCLINE DERIVATIVES FOR THE TREATMENT OF BACTERIAL, VIRAL AND PARASITIC INFECTIONS PARATEK PHARM INNC (US) 2014-02-12 EP disclosed
US-8466132-B2 Bactericides; antitumor agents; modulation of gene expression; malaria therapy; viricides; parasiticides; multiple sclerosis PARATEK PHARMACEUTICALS, INC. (US) 2013-06-18 US disclosed